XML 50 R40.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Information (Tables)
6 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Financial Information for Business Segments

The following is the summary of the financial information for the Company’s reportable segments for the three and six months ended March 31, 2021 and 2020 (in thousands):

Three Months Ended March 31, 

Six Months Ended March 31, 

2021

2020

2021

2020

Revenue:

  

 

  

 

  

Brooks Semiconductor Solutions Group

$

157,051

$

124,923

$

288,409

$

243,734

Brooks Life Sciences Products

52,355

30,993

97,866

60,717

Brooks Life Sciences Services

 

77,180

 

64,311

 

149,814

 

126,276

Total revenue

$

286,586

$

220,227

$

536,089

$

430,727

Operating income:

 

 

Brooks Semiconductor Solutions Group

$

33,302

$

16,707

$

54,840

$

31,707

Brooks Life Sciences Products

11,215

2,144

19,157

2,506

Brooks Life Sciences Services

 

13,406

 

5,973

 

27,717

 

11,585

Reportable segment adjusted operating income

57,923

24,824

101,714

45,798

Amortization of completed technology

2,319

2,740

4,708

5,416

Amortization of other intangible assets

7,601

7,615

14,957

15,525

Restructuring charges

92

578

179

1,154

Tariff adjustment

5,497

5,497

Other unallocated corporate expenses (income)

11,909

(681)

14,939

(1,535)

Total operating income

30,505

14,572

61,434

25,238

Interest income

18

137

94

836

Interest expense

(452)

(718)

(1,008)

(1,455)

Other income (expenses), net

149

(1,399)

1,478

(1,816)

Income before income taxes

$

30,220

$

12,592

$

61,998

$

22,803

Brooks

 

    

Semiconductor

Brooks Life

Brooks Life

Assets:

Solutions Group

Sciences Products

Sciences Services

Total

March 31, 2021

$

322,423

$

230,732

$

766,741

$

1,319,896

September 30, 2020

296,289

 

214,196

737,967

 

1,248,452

Reconciliation of Reportable Segment Assets to Corresponding Consolidated Amounts

    

March 31, 

    

September 30, 

2021

2020

Segment assets

    

$

1,319,896

    

$

1,248,452

Cash and cash equivalents, restricted cash, and marketable securities

 

334,336

 

305,694

Deferred tax assets

 

9,864

 

4,979

Total assets

$

1,664,096

$

1,559,125